Tyrosine Kinase Mutations in Endometrial Cancer
Demographics (1)
- sex - Gender of participant (phv00221198.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Case control status of the subject (phv00221190.v1.p1)
- age_onset - Disease onset age (phv00221197.v1.p1)
- TUMOR_DIFFERENTIATION - Tumor differentiation of sample (phv00221209.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00221208.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00221207.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00221199.v1.p1)
Other (17)
- ANALYTE TYPE - Analyte Type (phv00221202.v1.p1)
- BODY SITE - Body site where sample was collected (phv00221201.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00221189.v1.p1)
- HISTOLOGICAL TYPE - Cell or tissue type or subtype of sample (phv00221204.v1.p1)
- IS_TUMOR - Tumor status (phv00221203.v1.p1)
- PRIMARY TUMOR LOCATION - Primary tumor location (phv00221206.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00221205.v1.p1)
- SAMPLE_ID - Sample ID (phv00221200.v1.p1)
- SAMPLE_ID - Sample ID (phv00221192.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00221193.v1.p1)
- SAMPLE_USE - Sample Use (phv00221195.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00221211.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00221194.v1.p1)
- SUBJECT_ID - Subject ID (phv00221191.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00221196.v1.p1)
- SUBJECT_ID - Subject ID (phv00221188.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00221210.v1.p1)